Format

Send to

Choose Destination
Expert Opin Pharmacother. 2018 Nov 29:1-6. doi: 10.1080/14656566.2018.1550072. [Epub ahead of print]

Considerations when selecting pharmacotherapy for nicotine dependence.

Dodd S1,2,3,4, Arancini L1,4, Gómez-Coronado N5, Gasser R4, Lubman DI6,7, Dean OM1,3,4,8, Berk M1,2,3,4,8.

Author information

1
a School of Medicine , IMPACT SRC, Deakin University , Geelong , Australia.
2
b Centre for Youth Mental Health and Orygen , The National Centre of Excellence in Youth Mental Health, University of Melbourne , Parkville , Australia.
3
c Department of Psychiatry , University of Melbourne , Parkville , Australia.
4
d Barwon Health , University Hospital Geelong , Geelong , Australia.
5
e Department of Psychiatry , Hospital San Agustín-ORL , Seville , Spain.
6
f Turning Point, Eastern Health , Melbourne , Australia.
7
g Eastern Health Clinical School , Monash University , Melbourne , Australia.
8
h Florey Institute for Neuroscience and Mental Health , University of Melbourne , Parkville , Australia.

KEYWORDS:

Tobacco; nicotine dependence; novel therapies; pharmacotherapy; smoking cessation

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center